查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
呼吸道疾病疫苗市场规模、份额和趋势分析报告：按类型、年龄组、感染疾病、分销渠道、地区、细分市场预测，2023-2030年
市场调查报告书
商品编码
1321337

呼吸道疾病疫苗市场规模、份额和趋势分析报告：按类型、年龄组、感染疾病、分销渠道、地区、细分市场预测，2023-2030年

Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report By Type (Viral, Bacterial, Combination), By Age Group, By Infection (COVID-19, Influenza), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

呼吸道疾病疫苗市场增长和趋势

Grand View Research, Inc.最新报告显示，预计2023年至2030年全球呼吸道疫苗市场规模将以1.21%的复合年复合成长率增长，2030年将达到703亿美元。

呼吸道疾病疫苗市场的增长归因于人们对疫苗接种重要性的认识提高、呼吸道感染疾病发病率上升以及疫苗技术的进步。此外，COVID-19 大流行极大地凸显了呼吸道疫苗的重要性，进一步加速了市场的发展。

呼吸道疫苗，特别是针对流感和肺炎的疫苗，对于减轻医疗保健系统的负担并最大程度地降低与 COVID-19 合併感染的风险至关重要。为了防止病毒传播并防止疫情爆发，医疗保健提供者正在重点关注疫苗接种，以保护个人免受流感等呼吸道病原体的侵害。近年来，由于疫苗技术的进步，特别是针对SARS-CoV-2的疫苗的开发，呼吸道疫苗市场大幅增长。 COVID-19疫苗的成功开发、批准和部署证明了科学界快速应对呼吸道威胁的能力，并为呼吸道疫苗研发的未来进展铺平了道路。

此外，政府在国家和全球层面的支持和监督，以监测流感疫苗的供应、流行和实施，是推动市场增长的关键因素。此外，主要企业增加对新型疫苗市场引进的投资也有助于市场的增长。例如，辉瑞公司最近透露，计划于 2022 年 9 月开始其基于 mRNA 的流感疫苗的 3 期临床试验。该试验将涉及美国25,000 名 18 岁及以上的人。

此外，参与各种呼吸道疾病疫苗开发和配製的主要公司正在註重建立伙伴关係和协作，以开发新疫苗并保持市场竞争力。此外，人们对植物来源药物提供的自然疗法的兴趣日益浓厚，预计将在预测期内提振市场。此外，许多公司正在进行地域扩张和分销，以满足对药品不断增长的需求。例如，2023年5月，辉瑞公司的RSV疫苗ABRYSVO获得FDA批准，用于预防60岁及以上人群由RSV引起的下呼吸道疾病。

呼吸道疾病疫苗市场报告亮点

  • 按类型划分，由于病毒性呼吸道疾病的患病率不断上升，病毒疫苗细分市场在 2022 年占据了最大的销售份额。
  • 按年龄组划分，由于儿科人群疫苗配方的增加，预计儿科市场在预测期内将呈现最快的增长率。
  • 就感染疾病而言，由于开发疫苗以阻止 COVID-19 病毒传播的需求不断增长，2022 年，COVID-19 细分市场占据主导地位。
  • 市场上的主要企业不断关注地域扩张和产品发布，以保持自己的地位。
  • 由于主要参与者的存在、医疗基础设施的不断完善、慢性病病例的增加以及充足的疫苗接种服务的可用性，北美在 2022 年占据了最大的收入份额。

目录

第1章呼吸道疾病疫苗市场：调查方法和范围

  • 市场区隔和范围
    • 区域范围
    • 估计/预测时间表
    • 目的
  • 调查方法
  • 资讯采购
    • 购买数据库
    • GVR内部数据库
    • 次要资讯
    • 初步调查
  • 资讯或资料分析
    • 资料分析模型
  • 市场形成和检验
  • 型号详情
    • 产品流向分析
  • 二手资讯清单
  • 简称列表

第2章呼吸道疾病疫苗市场：执行摘要

  • 市场简介
  • 类型和年龄组简介
  • 传播渠道和感染简介
  • 竞争形势概览

第3章呼吸道疾病疫苗市场：行业展望

  • 市场谱系预测
    • 母公司市场谱系预测
    • 相关/附带市场预测
  • 采用和增长预测图
  • 市场动态
    • 市场促进因素
    • 市场抑制因素分析
  • 按因素（政治/法律、经济/技术）进行 SWOT 分析
  • 行业分析-波特
  • 赎回和法规场景
  • 主要交易和战略联盟
    • 新产品发布
    • 获得
    • 扩张
    • 合伙
    • 营销和推广

第4章呼吸系统疾病疫苗市场：竞争形势

  • 主要市场参与企业的最新趋势和影响分析
    • 安索夫矩阵
  • 企业分类
    • 创新者
  • 供应商形势
    • 主要经销商及渠道合作伙伴名单
    • 主要客户
    • 2022年主要企业市场份额分析
  • 上市公司
    • 竞争仪表板分析
  • 民营企业
    • 主要新兴企业名单
  • 区域网络图

第5章呼吸道疾病疫苗市场：类型业务分析

  • 定义和范围
  • 2022 年和 2030 年类型市场份额分析
  • 2018-2030 年全球呼吸道疾病疫苗市场（按类型）
  • 呼吸道疾病疫苗市场：类型变异分析
  • 病毒疫苗
  • 细菌疫苗
  • 联合疫苗

第6章呼吸系统疾病疫苗市场：按年龄组进行的业务分析

  • 定义和范围
  • 2022 年和 2030 年年龄段市场份额分析
  • 全球呼吸道疾病疫苗市场（按年龄组），2018-2030
  • 呼吸道疾病疫苗市场：年龄组变化分析
  • 孩子
  • 成人

第7章呼吸道疾病疫苗市场：感染疾病业务分析

  • 定义和范围
  • 2022 年和 2030 年感染疾病市场份额分析
  • 全球呼吸道疾病疫苗市场（按感染疾病），2018-2030
  • 呼吸道疾病疫苗市场：感染波动分析
  • COVID-19
  • 流感
  • RS病毒
  • 肺炎
  • 其他的

第8章呼吸道疾病疫苗市场：分销渠道业务分析

  • 定义和范围
  • 2022 年和 2030 年分销渠道市场份额分析
  • 2018-2030年全球呼吸道疾病疫苗市场（按分销渠道）
  • 呼吸道疾病疫苗市场：分销渠道波动分析
  • 医院和零售药房
    • 2018-2030 年医院和零售药房市场估计和预测
  • 政府供应商
  • 其他的

第9章呼吸系统疾病疫苗市场：区域业务分析

  • 定义和范围
  • 2022 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 区域市场简介
  • 按因素（政治/法律、经济/技术）进行 SWOT 分析
    • 北美
    • 欧洲
    • 亚太地区
    • 拉美
    • 中东/非洲
  • 2022年至2030年市场规模、预测、趋势分析
  • 北美
    • 2018年至2030年北美呼吸道疾病疫苗市场估计和预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030年欧洲呼吸道疾病疫苗市场
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 意大利
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 2018-2030年亚太呼吸系统疾病疫苗市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 鲷鱼
    • 澳大利亚
  • 拉美
    • 拉丁美洲呼吸道疾病疫苗市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 2018-2030年中东和非洲呼吸道疫苗市场
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第10章呼吸疫苗市场：公司概况

  • 企业分类
  • 战略规划
    • 新产品发布
    • 合伙
    • 获得
    • 合作
    • 资金筹措
  • 2022年主要企业市场份额分析
  • 公司简介
    • Gsk Plc.
    • Johnson & Johnson Services, Inc.
    • Pfizer Inc.
    • Sanofi
    • Serum Institute Of India Pvt. Ltd.
    • Sinovac
    • Bavarian Nordic
    • Merck & Co., Inc.
    • Astrazeneca
    • Emergent
    • Novavax
    • Inovio Pharmaceuticals
    • Moderna Inc.
Product Code: GVR-4-68040-093-9

Respiratory Disease Vaccine Market Growth & Trends

The global respiratory disease vaccine market size is expected to reach USD 70.30 billion by 2030, expanding at a CAGR of 1.21% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the respiratory disease vaccine market is attributable to increasing awareness associated with the importance of vaccination, the rising incidence of respiratory infections, and advancements in vaccine technology. Moreover, the COVID-19 pandemic has brought significant traction to the importance of respiratory vaccines which has further accelerated the market.

Respiratory vaccines, particularly those targeting influenza and pneumonia, are vital in reducing the burden on healthcare systems and minimizing the risk of co-infections with COVID-19. In order to prevent the spread of the virus and prevent the occurrence of outbreaks healthcare providers have been focusing on vaccination to protect individuals against respiratory pathogens like influenza. In recent years, the respiratory vaccine market has witnessed substantial growth attributed to advancements in vaccine technology, specifically in the development of vaccines targeting SARS-CoV-2. The successful development, approval, and deployment of COVID-19 vaccines have demonstrated the capacity of the scientific community to respond rapidly to respiratory threats and have paved the way for future advancements in respiratory vaccine research and development.

Moreover, government backing and surveillance at both national and global levels to monitor the availability, dissemination, and implementation of influenza vaccines is a crucial factor driving the growth of the market. Additionally, increased investments by prominent key players with a major focus on the introduction of novel vaccines into the market have contributed to the growth of the market. For instance, Pfizer recently disclosed their plans to commence Phase 3 clinical trials for their mRNA-based influenza vaccine in September 2022. This trial will involve a cohort of 25,000 individuals aged 18 and above from the U.S.

Furthermore, key players involved in developing and formulating various respiratory disease vaccines are focusing on collaborations and partnerships to develop novel vaccines and to maintain their competitive position in the market. In addition, increasing interest in plant-based medicines owing to natural remedies offered by them is expected to boost the market over the forecast period. Moreover, a number of players are involved in geographic expansion and distribution to meet the rising demand for medicinal products. For instance, in May 2023, Pfizer Inc. received FDA approval for ABRYSVO, a RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in the elderly population above the age of 60 years.

Respiratory Disease Vaccine Market Report Highlights

  • Based on type, the viral vaccine segment held the largest revenue share in 2022 owing to the increasing prevalence of viral respiratory conditions
  • Based on age group, the pediatric segment is expected to show the fastest growth rate over the forecast period owing to the rising formulation of vaccines for the pediatric population
  • On the basis of infection, the COVID-19 segment dominated in 2022 due to the growing need for the development of a vaccine to stop the spread of the COVID-19 virus
  • Key players operating in the market are constantly focusing on geographical expansion and product launches to maintain their presence
  • North America held the largest revenue share in 2022 which can be attributed to the presence of key players, rising healthcare infrastructure, growing cases of chronic disorders, and availability of proper vaccination service

Table of Contents

Chapter 1 Respiratory Disease Vaccine Market: Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Type Segment
      • 1.1.1.2 Age Group Segment
      • 1.1.1.3 Distribution Channel Segment
      • 1.1.1.4 Infection Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List Of Secondary Sources
  • 1.11 List Of Abbreviations

Chapter 2 Respiratory Disease Vaccine Market: Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Type And Age Group Snapshot
  • 2.3 Distribution Channel And Infection Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Respiratory Disease Vaccine Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Increasing Prevalence Of Respiratory Diseases
      • 3.3.1.2 Growing Awareness And Focus On Prevention
      • 3.3.1.3 Increasing Government Initiatives And Immunization Programs
      • 3.3.1.4 Growing Geriatric Population
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Complex And Time-Consuming Regulatory Approval Process
      • 3.3.2.2 High Price Associated With Vaccines
  • 3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions

Chapter 4 Respiratory Disease Vaccine Market: Competitive Landscape

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 4.1.1 Ansoff Matrix
  • 4.2 Company Categorization
    • 4.2.1 Innovators
      • 4.2.1.1 Market Differentiators
  • 4.3 Vendor Landscape
    • 4.3.1 List Of Key Distributors And Channel Partners
    • 4.3.2 Key Customers
    • 4.3.3 Key Company Market Share Analysis, 2022
  • 4.4 Public Companies
    • 4.4.1 Competitive Dashboard Analysis
  • 4.5 Private Companies
    • 4.5.1 List Of Key Emerging Companies
  • 4.6 Regional Network Map

Chapter 5 Respiratory Disease Vaccine Market: Type Business Analysis

  • 5.1 Definition And Scope
  • 5.2 Type Market Share Analysis, 2022 & 2030
  • 5.3 Global Respiratory Disease Vaccine Market, By Type, 2018 To 2030
  • 5.4 Respiratory Disease Vaccine Market: Type Movement Analysis
  • 5.5 Viral Vaccine
    • 5.5.1 Viral Vaccine Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 Bacterial Vaccine
    • 5.6.1 Bacterial Vaccine Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7 Combination Vaccine
    • 5.7.1 Combination Vaccine Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Respiratory Disease Vaccine Market: Age Group Business Analysis

  • 6.1 Definition And Scope
  • 6.2 Age Group Market Share Analysis, 2022 & 2030
  • 6.3 Global Respiratory Disease Vaccine Market, By Age Group, 2018 To 2030
  • 6.4 Respiratory Disease Vaccine Market: Age Group Movement Analysis
  • 6.5 Pediatric
    • 6.5.1 Pediatric Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.6 Adult
    • 6.6.1 Adult Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Respiratory Disease Vaccine Market: Infection Business Analysis

  • 7.1 Definition And Scope
  • 7.2 Infection Market Share Analysis, 2022 & 2030
  • 7.3 Global Respiratory Disease Vaccine Market, By Infection, 2018 To 2030
  • 7.4 Respiratory Disease Vaccine Market: Infection Movement Analysis
  • 7.5 Covid-19
    • 7.5.1 Covid-19 Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.6 Influenza
    • 7.6.1 Influenza Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.7 Respiratory Syncytial Virus (Rsv)
    • 7.7.1 Respiratory Syncytial Virus (Rsv) Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.8 Pneumonia
    • 7.8.1 Pneumonia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.9 Others
    • 7.9.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Respiratory Disease Vaccine Market: Distribution Channel Business Analysis

  • 8.1 Definition And Scope
  • 8.2 Distribution Channel Market Share Analysis, 2022 & 2030
  • 8.3 Global Respiratory Disease Vaccine Market, By Distribution Channel, 2018 To 2030
  • 8.4 Respiratory Disease Vaccine Market: Distribution Channel Movement Analysis
  • 8.5 Hospital & Retail Pharmacies
    • 8.5.1 Hospital & Retail Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6 Government Suppliers
    • 8.6.1 Government Suppliers Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.7 Others
    • 8.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Respiratory Disease Vaccine Market: Regional Business Analysis

  • 9.1 Definition & Scope
  • 9.2 Regional Market Share Analysis, 2022 & 2030
  • 9.3 Regional Market Dashboard
  • 9.4 Regional Market Snapshot
  • 9.5 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 9.5.1 North America
    • 9.5.2 Europe
    • 9.5.3 Asia Pacific
    • 9.5.4 Latin America
    • 9.5.5 MEA
  • 9.6 Market Size, & Forecasts, Trend Analysis, 2022 To 2030
  • 9.7 North America
    • 9.7.1 North America Respiratory Disease Vaccine Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 9.7.2 U.S.
      • 9.7.2.1 U.S. Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.7.2.2 Key Country Dynamics
      • 9.7.2.3 Regulatory Framework
      • 9.7.2.4 Competitive Scenario
    • 9.7.3 Canada
      • 9.7.3.1 Canada Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.7.3.2 Key Country Dynamics
      • 9.7.3.3 Regulatory Framework
      • 9.7.3.4 Competitive Scenario
  • 9.8 Europe
    • 9.8.1 Europe Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
    • 9.8.2 Uk
      • 9.8.2.1 Uk Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.2.2 Key Country Dynamics
      • 9.8.2.3 Regulatory Framework
      • 9.8.2.4 Competitive Scenario
    • 9.8.3 Germany
      • 9.8.3.1 Germany Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.3.2 Key Country Dynamics
      • 9.8.3.3 Regulatory Framework
      • 9.8.3.4 Competitive Scenario
    • 9.8.4 Spain
      • 9.8.4.1 Spain Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.4.2 Key Country Dynamics
      • 9.8.4.3 Regulatory Framework
      • 9.8.4.4 Competitive Scenario
    • 9.8.5 France
      • 9.8.5.1 France Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.5.2 Key Country Dynamics
      • 9.8.5.3 Regulatory Framework
      • 9.8.5.4 Competitive Scenario
    • 9.8.6 Italy
      • 9.8.6.1 Italy Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.6.2 Key Country Dynamics
      • 9.8.6.3 Regulatory Framework
      • 9.8.6.4 Competitive Scenario
    • 9.8.7 Norway
      • 9.8.7.1 Norway Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.7.2 Key Country Dynamics
      • 9.8.7.3 Regulatory Framework
      • 9.8.7.4 Competitive Scenario
    • 9.8.8 Denmark
      • 9.8.8.1 Denmark Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.8.2 Key Country Dynamics
      • 9.8.8.3 Regulatory Framework
      • 9.8.8.4 Competitive Scenario
    • 9.8.9 Sweden
      • 9.8.9.1 Sweden Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.8.9.2 Key Country Dynamics
      • 9.8.9.3 Regulatory Framework
      • 9.8.9.4 Competitive Scenario
  • 9.9 Asia Pacific
    • 9.9.1 Asia Pacific Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
    • 9.9.2 Japan
      • 9.9.2.1 Japan Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.9.2.2 Key Country Dynamics
      • 9.9.2.3 Regulatory Framework
      • 9.9.2.4 Competitive Scenario
    • 9.9.3 China
      • 9.9.3.1 China Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.9.3.2 Key Country Dynamics
      • 9.9.3.3 Regulatory Framework
      • 9.9.3.4 Competitive Scenario
    • 9.9.4 India
      • 9.9.4.1 India Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.9.4.2 Key Country Dynamics
      • 9.9.4.3 Regulatory Framework
      • 9.9.4.4 Competitive Scenario
    • 9.9.5 South Korea
      • 9.9.5.1 South Korea Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.9.5.2 Key Country Dynamics
      • 9.9.5.3 Regulatory Framework
      • 9.9.5.4 Competitive Scenario
    • 9.9.6 Thailand
      • 9.9.6.1 Thailand Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.9.6.2 Key Country Dynamics
      • 9.9.6.3 Regulatory Framework
      • 9.9.6.4 Competitive Scenario
    • 9.9.7 Australia
      • 9.9.7.1 Australia Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.9.7.2 Key Country Dynamics
      • 9.9.7.3 Regulatory Framework
      • 9.9.7.4 Competitive Scenario
  • 9.10 Latin America
    • 9.10.1 Latin America Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
    • 9.10.2 Brazil
      • 9.10.2.1 Brazil Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.10.2.2 Key Country Dynamics
      • 9.10.2.3 Regulatory Framework
      • 9.10.2.4 Competitive Scenario
    • 9.10.3 Mexico
      • 9.10.3.1 Mexico Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.10.3.2 Key Country Dynamics
      • 9.10.3.3 Regulatory Framework
      • 9.10.3.4 Competitive Scenario
    • 9.10.4 Argentina
      • 9.10.4.1 Argentina Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.10.4.2 Key Country Dynamics
      • 9.10.4.3 Regulatory Framework
      • 9.10.4.4 Competitive Scenario
  • 9.11 MEA
    • 9.11.1 MEA Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
    • 9.11.2 South Africa
      • 9.11.2.1 South Africa Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.11.2.2 Key Country Dynamics
      • 9.11.2.3 Regulatory Framework
      • 9.11.2.4 Competitive Scenario
    • 9.11.3 Saudi Arabia
      • 9.11.3.1 Saudi Arabia Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.11.3.2 Key Country Dynamics
      • 9.11.3.3 Regulatory Framework
      • 9.11.3.4 Competitive Scenario
    • 9.11.4 UAE
      • 9.11.4.1 UAE Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.11.4.2 Key Country Dynamics
      • 9.11.4.3 Regulatory Framework
      • 9.11.4.4 Competitive Scenario
    • 9.11.5 Kuwait
      • 9.11.5.1 Kuwait Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
      • 9.11.5.2 Key Country Dynamics
      • 9.11.5.3 Regulatory Framework
      • 9.11.5.4 Competitive Scenario

Chapter 10 Respiratory Disease Vaccine Market: Company Profiling

  • 10.1 Company Categorization
  • 10.2 Strategy Mapping
    • 10.2.1 New Product Launch
    • 10.2.2 Partnerships
    • 10.2.3 Acquisition
    • 10.2.4 Collaboration
    • 10.2.5 Funding
  • 10.3 Key Company Market Share Analysis, 2022
  • 10.4 Company Profiles
    • 10.4.1 Gsk Plc.
      • 10.4.1.1 Company Overview
      • 10.4.1.2 Financial Performance
      • 10.4.1.3 Product Benchmarking
      • 10.4.1.4 Strategic Initiatives
    • 10.4.2 Johnson & Johnson Services, Inc.
      • 10.4.2.1 Company Overview
      • 10.4.2.2 Financial Performance
      • 10.4.2.3 Product Benchmarking
      • 10.4.2.4 Strategic Initiatives
    • 10.4.3 Pfizer Inc.
      • 10.4.3.1 Company Overview
      • 10.4.3.2 Financial Performance
      • 10.4.3.3 Product Benchmarking
      • 10.4.3.4 Strategic Initiatives
    • 10.4.4 Sanofi
      • 10.4.4.1 Company Overview
      • 10.4.4.2 Financial Performance
      • 10.4.4.3 Product Benchmarking
      • 10.4.4.4 Strategic Initiatives
    • 10.4.5 Serum Institute Of India Pvt. Ltd.
      • 10.4.5.1 Company Overview
      • 10.4.5.2 Product Benchmarking
      • 10.4.5.3 Strategic Initiatives
    • 10.4.6 Sinovac
      • 10.4.6.1 Company Overview
      • 10.4.6.2 Product Benchmarking
      • 10.4.6.3 Strategic Initiatives
    • 10.4.7 Bavarian Nordic
      • 10.4.7.1 Company Overview
      • 10.4.7.2 Financial Performance
      • 10.4.7.3 Product Benchmarking
      • 10.4.7.4 Strategic Initiatives
    • 10.4.8 Merck & Co., Inc.
      • 10.4.8.1 Company Overview
      • 10.4.8.2 Financial Performance
      • 10.4.8.3 Product Benchmarking
      • 10.4.8.4 Strategic Initiatives
    • 10.4.9 Astrazeneca
      • 10.4.9.1 Company Overview
      • 10.4.9.2 Financial Performance
      • 10.4.9.3 Product Benchmarking
      • 10.4.9.4 Strategic Initiatives
    • 10.4.10 Emergent
      • 10.4.10.1 Company Overview
      • 10.4.10.2 Financial Performance
      • 10.4.10.3 Product Benchmarking
      • 10.4.10.4 Strategic Initiatives
    • 10.4.11 Novavax
      • 10.4.11.1 Company Overview
      • 10.4.11.2 Financial Performance
      • 10.4.11.3 Product Benchmarking
      • 10.4.11.4 Strategic Initiatives
    • 10.4.12 Inovio Pharmaceuticals
      • 10.4.12.1 Company Overview
      • 10.4.12.2 Financial Performance
      • 10.4.12.3 Product Benchmarking
      • 10.4.12.4 Strategic Initiatives
    • 10.4.13 Moderna Inc.
      • 10.4.13.1 Company Overview
      • 10.4.13.2 Financial Performance
      • 10.4.13.3 Product Benchmarking
      • 10.4.13.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Respiratory Disease Vaccine Market, By Region, 2018 - 2030 (USD Million)
  • Table 4 Global Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 5 Global Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 6 Global Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 7 Global Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 8 North America Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 North America Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 11 North America Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 12 North America Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 U.S. Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 U.S. Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 15 U.S. Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 16 U.S. Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 17 Canada Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 19 Canada Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 20 Canada Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 21 Europe Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Europe Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 24 Europe Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 25 Europe Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 Germany Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 Germany Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 28 Germany Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 29 Germany Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 30 UK Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 31 UK Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 32 UK Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 33 UK Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 France Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 France Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 36 France Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 37 France Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Italy Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 40 Italy Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 41 Italy Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 42 Spain Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Spain Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 44 Spain Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 45 Spain Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46 Denmark Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Denmark Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 48 Denmark Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 49 Denmark Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 Sweden Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Sweden Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 52 Sweden Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 53 Sweden Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 Norway Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 55 Norway Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 56 Norway Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 57 Norway Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63 Japan Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 64 Japan Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 65 Japan Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 66 Japan Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 67 China Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 68 China Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 69 China Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 70 China Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 71 India Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 72 India Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 73 India Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 74 India Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 South Korea Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 76 South Korea Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 77 South Korea Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 78 South Korea Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 Australia Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 80 Australia Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 81 Australia Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 82 Australia Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 Thailand Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 84 Thailand Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 85 Thailand Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 86 Thailand Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 87 Latin America Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Latin America Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 90 Latin America Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 91 Latin America Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92 Brazil Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 93 Brazil Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 94 Brazil Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 95 Brazil Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 96 Mexico Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 97 Mexico Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 98 Mexico Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 99 Mexico Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 100 Argentina Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 101 Argentina Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 102 Argentina Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 103 Argentina Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 111 Saudi Arabia Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 113 South Africa Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 114 South Africa Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 115 South Africa Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 116 South Africa Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 117 UAE Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 118 UAE Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 119 UAE Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 120 UAE Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Respiratory Disease Vaccine Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Respiratory disease vaccine market: Type outlook and key takeaways
  • Fig. 15 Respiratory disease vaccine market: Type movement analysis & market share 2022 & 2030
  • Fig. 16 Viral vaccines market, 2018 - 2030 (USD Million)
  • Fig. 17 Bacterial vaccine market, 2018 - 2030 (USD Million)
  • Fig. 18 Combination vaccine market, 2018 - 2030 (USD Million)
  • Fig. 19 Respiratory disease vaccine market: Age group outlook and key takeaways
  • Fig. 20 Respiratory disease vaccine market: Age group movement analysis & market share 2022 & 2030
  • Fig. 21 Pediatric market, 2018 - 2030 (USD Million)
  • Fig. 22 Adult market, 2018 - 2030 (USD Million)
  • Fig. 23 Respiratory disease vaccine market: Infection outlook and key takeaways
  • Fig. 24 Respiratory disease vaccine market: Infection movement analysis & market share 2022 & 2030
  • Fig. 25 COVID-19 market, 2018 - 2030 (USD Million)
  • Fig. 26 Influenza market, 2018 - 2030 (USD Million)
  • Fig. 27 Respiratory syncytial virus (RSV) market, 2018 - 2030 (USD Million)
  • Fig. 28 Pneumonia market, 2018 - 2030 (USD Million)
  • Fig. 29 Others antifungal drugs market, 2018 - 2030 (USD Million)
  • Fig. 30 Respiratory disease vaccine market: Distribution channel outlook and key takeaways
  • Fig. 31 Respiratory disease vaccine market: Distribution channel movement analysis & market share 2022 & 2030
  • Fig. 32 Hospital & retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Government suppliers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Regional Marketplace: Key Takeaways
  • Fig. 36 Regional Outlook, 2022 & 2030
  • Fig. 37 Regional Market Dashboard
  • Fig. 38 Regional Market Place: Key Takeaways
  • Fig. 39 North America, SWOT Analysis
  • Fig. 40 Europe, SWOT Analysis
  • Fig. 41 Asia Pacific, SWOT Analysis
  • Fig. 42 Latin America, SWOT Analysis
  • Fig. 43 MEA, SWOT Analysis
  • Fig. 44 North America
  • Fig. 45 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Key Country Dynamics
  • Fig. 47 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Canada Key Country Dynamics
  • Fig. 49 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Europe
  • Fig. 51 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 52 UK Key Country Dynamics
  • Fig. 53 UK Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Germany Key Country Dynamics
  • Fig. 55 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 56 France Key Country Dynamics
  • Fig. 57 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Italy Key Country Dynamics
  • Fig. 59 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Spain Key Country Dynamics
  • Fig. 61 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark Key Country Dynamics
  • Fig. 63 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Sweden Key Country Dynamics
  • Fig. 65 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Norway Key Country Dynamics
  • Fig. 67 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Asia Pacific Key Country Dynamics
  • Fig. 69 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Japan Key Country Dynamics
  • Fig. 71 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 72 China Key Country Dynamics
  • Fig. 73 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 74 India
  • Fig. 75 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Australia Key Country Dynamics
  • Fig. 77 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Thailand Key Country Dynamics
  • Fig. 79 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 80 South Korea Key Country Dynamics
  • Fig. 81 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Latin America
  • Fig. 83 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Brazil Key Country Dynamics
  • Fig. 85 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Mexico Key Country Dynamics
  • Fig. 87 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Argentina Key Country Dynamics
  • Fig. 89 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 90 MEA
  • Fig. 91 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 92 South Africa Key Country Dynamics
  • Fig. 93 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Saudi Arabia Key Country Dynamics
  • Fig. 95 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 96 UAE Key Country Dynamics
  • Fig. 97 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Kuwait Key Country Dynamics
  • Fig. 99 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Strategy Mapping